Sfoglia per AUTORE
YAKOUB-AGHA I
Collezione AOU Città della Salute di Torino

  

Items : 8

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Sep;57(9):1421-1427. doi: 10.1038/s41409-022-01674-x. Epub 2022 Jun 25.

2022
AOU Città della Salute di Torino

Neubauer A; Avenoso D; Yakoub-Agha I; Arroyo H; Bay JO; Olivieri A; Vrhovac R; Charbonnier A; Bruno B; Bug G; Stölzel F; Martino M; Chalandon Y; Socié G; Castagna L; Pavlu J; Raiola AM; Blaise D; Labopin M; Galimard JE; Devillier R; Nguyen S; Forcade E; Brissot E; Savani B; Nagler A; Mohty M;

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). in Bone marrow transplantation / Bone Marrow Transplant. 2022 Dec;57(12):1803-1809. doi: 10.1038/s41409-022-01830-3. Epub 2022 Sep 22

2022
AOU Città della Salute di Torino

Bazarbachi A; Giebel S; Savani B; Anagnostopoulos A; Ozdogu H; Sanz J; Busca A; Zuckerman T; Mielke S; Kröger N; Hilgendorf I; Rambaldi A; Berceanu A; Potter V; Yakoub-Agha I; Salmenniemi U; Sakellari I; Gavriilaki E; Labopin M; Spyridonidis A; Nagler A; Mohty M;

Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. in Frontiers in immunology / Front Immunol. 2021 Dec 21;12:813838. doi: 10.3389/fimmu.2021.813838. eCollection 2021.

2021
AOU Città della Salute di Torino

Kröger N; Lee SJ; Hayden P; Schaap N; Ljungman P; Potter V; Massalski C; Lange V; Onida F; Bruno B; van Gelder M; Spellman S; de Wreede LC; Heidenreich F; Kuxhausen M; Koster L; Schetelig J; Baldauf H; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M;

Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. in Frontiers in immunology / Front Immunol. 2021 Jan 19;11:584520. doi: 10.3389/fimmu.2020.584520. eCollection 2020.

2020
AOU Città della Salute di Torino

Kröger N; Lee SJ; Hayden P; Schaap N; Ljungman P; Potter V; Massalski C; Lange V; Onida F; Bruno B; van Gelder M; Spellman S; de Wreede LC; Heidenreich F; Kuxhausen M; Koster L; Schetelig J; Baldauf H; Hsu K; Schmidt AH; Yakoub-Agha I; Robin M;

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies. in Frontiers in immunology / Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020.

2020
AOU Città della Salute di Torino

Schoemans H; Kroschinsky F; Yakoub-Agha I; Sengeloev H; Scheid C; Niederwieser D; Ladetto M; Afanasyev B; Corradini P; Kröger N; Castagna L; Rambaldi A; Socié G; Bruno B; Solano C; Chevallier P; Bourhis JH; Ciceri F; Reményi P; Milpied N; Kanfer E; van der Werf S; Blaise D; Beohou E; Jagasia M; Tomaszewska A; Koenecke C; Penack O; Peri? Z; et alii...

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia. in American journal of hematology / Am J Hematol. 2018 Oct;93(10):1211-1219. doi: 10.1002/ajh.25225. Epub 2018 Aug 15.

2018
AOU Città della Salute di Torino

Saraceni F; Beohou E; Labopin M; Arcese W; Bonifazi F; Stepensky P; Aljurf M; Bruno B; Pioltelli P; Passweg J; Sociè G; Santarone S; Yakoub-Agha I; Lanza F; Savani BN; Mohty M; Nagler A; Saraceni F; Beohou E; Labopin M; Arcese W; Bonifazi F; Stepensky P; Aljurf M; Bruno B; Pioltelli P; Passweg J; Sociè G; Santarone S; et alii...

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. in British journal of haematology / Br J Haematol. 2018 Aug;182(3):418-422. doi: 10.1111/bjh.15407. Epub 2018 May 29.

2018
AOU Città della Salute di Torino

Ljungman P; Gedde-Dahl T; Cornelissen JJ; Bruno B; Beguin Y; Bay JO; Socié G; Schaap M; Itälä-Remes M; Holler E; Griskevicius L; Carlson K; Vitek A; Finke J; Van Lint MT; Blok HJP; Koster L; van Biezen A; Robin M; Szydlo R; McLornan DP; Rubio MT; Yakoub-Agha I; Klyuchnikov E; Olavarria E; Chalandon Y; Kröger N; McLornan DP; Szydlo R; et alii...

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes. in Bone marrow transplantation / Bone Marrow Transplant. 2017 Aug;52(8):1107-1112. doi: 10.1038/bmt.2017.19. Epub 2017 Mar 20.

2017
AOU Città della Salute di Torino

Alvarez AF; Kalhs P; Rovira M; Leblond V; Or R; Maertens J; Volin L; Yakoub-Agha I; Bruno B; Veelken JH; Mufti GJ; Alessandrino EP; Vigouroux S; Beelen D; Finke J; Schaap N; van Lint M; Henseler A; Martino R; Vitek A; Sierra J; Wagner E; Robin M; de Witte T; Kröger N;